What’s Going On With Arcus Biosciences Stock On Wednesday?

All NewsApril 22, 2026

Arcus Biosciences halts STAR-121 lung cancer trial after futility review while Gilead Science declines option extension.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent